The Effect of Time-Restricted Eating on Insulin Levels and Insulin Sensitivity in Patients with Polycystic Ovarian Syndrome: A Systematic Review

The Effect of Time-Restricted Eating on Insulin Levels and Insulin Sensitivity in Patients with Polycystic Ovarian Syndrome: A Systematic Review

Background & Objective. Polycystic ovarian syndrome (PCOS) is the most common reproductive endocrinopathy in women of reproductive age with many associated metabolic symptoms, in particular hyperinsulinemia, insulin resistance, and a high lifetime risk of type 2 diabetes mellitus. The effects of...

Full description

Saved in:

Bibliographic Details
Main Authors:	R. Floyd, R. Gryson, D. Mockler, J. Gibney, S. N. Duggan, L. A. Behan
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	International Journal of Endocrinology
Online Access:	http://dx.doi.org/10.1155/2022/2830545
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of immunity in insulin resistance in patients with polycystic ovary syndrome
by: Qixuan Zhang, et al.
Published: (2025-01-01)

Hydroxychloroquine enhances insulin sensitivity and ameliorates abnormal lipid metabolism in obese women with polycystic ovary syndrome
by: Ruihan Wang, et al.
Published: (2025-01-01)

Age, Body Mass Index, and Waist-to-Hip Ratio Related Changes in Insulin Secretion and Insulin Sensitivity in Women with Polycystic Ovary Syndrome: Minimal Model Analyses
by: Mirjana Šumarac-Dumanović, et al.
Published: (2022-01-01)

Fecal propionate is a signature of insulin resistance in polycystic ovary syndrome
by: Sitong Dong, et al.
Published: (2025-01-01)

The role of diet therapy in insulin resistance in women with polycystic ovary syndrome
by: H.B. Semenyna, et al.
Published: (2025-01-01)

Is it feasible to treat polycystic ovarian syndrome with or without insulin resistance using glucokinase activators as novel hypoglycaemic medications? A protocol for a systematic review and meta-analysis
by: Xiaojing Liu, et al.
Published: (2024-12-01)

Pathophysiologic Mechanisms of Insulin Secretion and Signaling-Related Genes in Etiology of Polycystic Ovary Syndrome
by: Zahra Shaaban, et al.
Published: (2021-01-01)

Serum Zinc Levels in Women with Polycystic Ovarian Syndrome are Lower as Compared to Those without Polycystic Ovarian Syndrome: A Cohort Study
by: Swati Dhar, et al.
Published: (2024-01-01)

Insulin Autoimmune Syndrome: A Systematic Review
by: MingXu Lin, et al.
Published: (2023-01-01)

Prevalence and Clinical Predictors of Insulin Resistance in Reproductive-Aged Thai Women with Polycystic Ovary Syndrome
by: Thanyarat Wongwananuruk, et al.
Published: (2012-01-01)

Relationship between Adiponectin Level, Insulin Sensitivity, and Metabolic Syndrome in Type 1 Diabetic Patients
by: Kristina Blaslov, et al.
Published: (2013-01-01)

Prediction of Insulin Resistance and Impaired Fasting Glucose Based on Sex Hormone-Binding Globulin (SHBG) Levels in Polycystic Ovary Syndrome
by: Aleksandra Biernacka-Bartnik, et al.
Published: (2022-01-01)

Insulin-Like Growth Factor (IGF)-I and Insulin in Normal and Growth-Restricted Mother/Infant Pairs
by: Ariadne Malamitsi-Puchner, et al.
Published: (2007-01-01)

Cross-Talk between PPARγ and Insulin Signaling and Modulation of Insulin Sensitivity
by: Anna Leonardini, et al.
Published: (2009-01-01)

A Case–Control Study of the Association of Novel Androgens (11-KT and DHT), Classical Androgens (Testosterone and DHEAS), Hormones (LH, FSH, 17-OHP, Insulin, and SHBG), Insulin Resistance (HOMA-IR), and Dyslipidemia in Polycystic Ovarian Syndrome (PCOS)
by: Nirmal Kumar, et al.
Published: (2025-01-01)

SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome
by: Barbara Šenk, et al.
Published: (2018-01-01)

Association of insulin resistance surrogates with live birth outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization
by: Shenghao Wu, et al.
Published: (2025-01-01)

Treatment with Metformin Can Improve Insulin Resistance and Lipid Profile in Non-Diabetic Iraqi Women with Polycystic Ovary Syndrome
by: Ali M. Kadim Al-Tuma, et al.
Published: (2024-10-01)

Prevalence Of Skin Manifestations In Patients With Polycystic Ovarian Syndrome
by: Tehseen Naveed, et al.
Published: (2024-03-01)

From Placenta to Polycystic Ovarian Syndrome: The Role of Adipokines
by: Chiara Sartori, et al.
Published: (2016-01-01)

Evaluating the effects of time-restricted eating on overweight and obese women with polycystic ovary syndrome: A randomized controlled trial study protocol.
by: Hui Liu, et al.
Published: (2025-01-01)

Plasma Diaphanous Related Formin 1 Levels Are Associated with Altered Glucose Metabolism and Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Case Control Study
by: Xing Li, et al.
Published: (2022-01-01)

Serum Concentrations of Betatrophin and Its Association with Indirect Indices of Insulin Resistance and Beta Cell Function in Women with Polycystic Ovary Syndrome
by: Agnieszka Adamska, et al.
Published: (2017-01-01)

Insulin signaling and dietary restriction differentially influence the decline of learning and memory with age.
by: Amanda L Kauffman, et al.
Published: (2010-05-01)

Effects of Aerobic Exercise on Rats with Hyperandrogenic Polycystic Ovarian Syndrome
by: Na Li, et al.
Published: (2021-01-01)

Polycystic ovary syndrome in a patient with type B insulin resistance syndrome can improve with glucocorticoid treatment: a case report and literature review
by: Tetsuhiro Watanabe, et al.
Published: (2023-10-01)

Comparison Of Glucagon Like Peptide/1 Levels In Diabetic Women With Ovarian Polycystic Syndrome And Healthy Women
by: Namra Iqtidar, et al.
Published: (2024-09-01)

Hyperandrogenism-Insulin Resistance-Acanthosis Nigricans Syndrome
by: A. H. Dédjan, et al.
Published: (2015-01-01)

Modulating DDAH/NOS Pathway to Discover Vasoprotective Insulin Sensitizers
by: Li Lai, et al.
Published: (2016-01-01)

The Role of Insulin, Insulin Growth Factor, and Insulin-Degrading Enzyme in Brain Aging and Alzheimer's Disease
by: Claude Messier, et al.
Published: (2005-01-01)

The Role of Visfatin, Leptin, and IL-18 in Polycystic Ovarian Syndrome Patients
by: Sukayna H. Rashed, et al.
Published: (2024-12-01)

Prolidase activity in women with polycystic ovarian syndrome undergoing assisted conception
by: Kadriye Erdoğan, et al.
Published: (2024-12-01)

The Usefulness of Homeostatic Measurement Assessment-Insulin Resistance (HOMA-IR) for Detection of Glucose Intolerance in Thai Women of Reproductive Age with Polycystic Ovary Syndrome
by: Thanyarat Wongwananuruk, et al.
Published: (2012-01-01)

Short-Term Exercise Training Improves Insulin Sensitivity but Does Not Inhibit Inflammatory Pathways in Immune Cells from Insulin-Resistant Subjects
by: Sara M. Reyna, et al.
Published: (2013-01-01)

Metabolic Syndrome in Estonia: Prevalence and Associations with Insulin Resistance
by: Triin Eglit, et al.
Published: (2012-01-01)

Perspectives on diacylglycerol-induced improvement of insulin sensitivity in type 2 diabetes
by: Daoming Li, et al.
Published: (2022-03-01)

Correction: Yamarthi et al. <i>Sepia pharaonis</i> Ink Mitigates Dehydroepiandrosterone-Induced Insulin Resistance in Mouse Model of Polycystic Ovarian Syndrome. <i>Pathophysiology</i> 2024, <i>31</i>, 408–419
by: Prathyusha Yamarthi, et al.
Published: (2025-01-01)

A Study of Serum Adiponectin Levels in Patients with Polycystic Ovarian Syndrome and its Correlation with Various Cardiometabolic Risk Markers
by: G. Surendra Prasad, et al.
Published: (2023-10-01)

Detection of Insulin in Insulin-Deficient Islets of Patients with Type 1 Diabetes
by: Yuliya Krivova, et al.
Published: (2025-01-01)

High Fasting Insulin Levels and Insulin Resistance May Be Linked to Idiopathic Recurrent Pregnancy Loss: A Case-Control Study
by: Corina-Alina Ispasoiu, et al.
Published: (2013-01-01)